The major event of global oncology, which is the annual conference of the American Society of Clinical Oncology (ASCO), is about to begin, and important studies on effective strategies to reduce cancer risk, mitigate its effects or progression, and improve patients’ overall lives are beginning to spread. Three of the first studies focus on the Mediterranean diet, weight control, and the use of new drugs (LPG-1 agonists) for weight loss.
The major event of global oncology, which is the annual conference of the American Society of Clinical Oncology (ASCO), is about to begin, and important studies on effective strategies to reduce cancer risk, mitigate its effects or progression, and improve patients’ overall lives are beginning to spread. Three of the first studies focus on the Mediterranean diet, weight control, and the use of new drugs (LPG-1 agonists) for weight loss.